Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Shares Outstanding (2019 - 2025)

Historic Shares Outstanding for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $54.1 million.

  • Fulcrum Therapeutics' Shares Outstanding rose 31.48% to $54.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.1 million, marking a year-over-year increase of 31.48%. This contributed to the annual value of $54.0 million for FY2024, which is 1283.54% down from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Shares Outstanding of $54.1 million as of Q3 2025, which was up 31.48% from $54.1 million recorded in Q2 2025.
  • Fulcrum Therapeutics' Shares Outstanding's 5-year high stood at $62.3 million during Q2 2024, with a 5-year trough of $32.6 million in Q1 2021.
  • In the last 5 years, Fulcrum Therapeutics' Shares Outstanding had a median value of $54.0 million in 2024 and averaged $51.3 million.
  • As far as peak fluctuations go, Fulcrum Therapeutics' Shares Outstanding soared by 5180.32% in 2023, and later plummeted by 1313.42% in 2025.
  • Fulcrum Therapeutics' Shares Outstanding (Quarter) stood at $40.6 million in 2021, then rose by 28.24% to $52.1 million in 2022, then increased by 18.84% to $61.9 million in 2023, then fell by 12.84% to $54.0 million in 2024, then grew by 0.26% to $54.1 million in 2025.
  • Its Shares Outstanding was $54.1 million in Q3 2025, compared to $54.1 million in Q2 2025 and $54.0 million in Q1 2025.